Incyte Corp. (NASDAQ:INCY) had its price objective hosited by JMP Securities from $29.00 to $40.00 in a report released on Tuesday, ARN reports. JMP Securities currently has a market outperform rating on the stock.
A number of other analysts have also recently weighed in on INCY. Analysts at Jefferies Group reiterated a buy rating on shares of Incyte Corp. (NASDAQ:INCY) in a research note to investors on Thursday, August 22nd. They now have a $44.00 price target on the stock, up previously from $36.00. Separately, analysts at Goldman Sachs Group Inc. reiterated a sell rating on shares of Incyte Corp. (NASDAQ:INCY) in a research note to investors on Thursday, August 22nd. Finally, analysts at Brean Capital reiterated a buy rating on shares of Incyte Corp. (NASDAQ:INCY) in a research note to investors on Wednesday, August 21st.
Two investment analysts have rated the stock with a sell rating, two have given a hold rating and thirteen have issued a buy rating to the company’s stock. Incyte Corp. currently has a consensus rating of Buy and an average price target of $29.92.
Shares of Incyte Corp. (NASDAQ:INCY) traded up 1.36% on Tuesday, hitting $35.05. 912,758 shares of the company’s stock traded hands. Incyte Corp. has a 1-year low of $15.43 and a 1-year high of $37.46. The stock has a 50-day moving average of $27.89 and a 200-day moving average of $23.65. The company’s market cap is $5.365 billion. Incyte Corp. also was the target of some unusual options trading activity on Monday. Traders acquired 1,229 put options on the stock. This is an increase of approximately 116% compared to the typical volume of 570 put options.
Incyte Corporation (NASDAQ:INCY) is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat serious unmet medical needs.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.